Anesthesia Updates

--------------------------------------------------------- ⁠⁠

Bleeding in the Young: Rethinking Hemostasis in Pediatric Surgery

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

1 week ago

5 minutes 21 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic discusses a 2025 review that reshapes how we manage bleeding in children. From restrictive transfusion thresholds and viscoelastic testing to the revival of whole blood and smarter use of TXA, pediatric hemostasis is entering a new era. Tune in to learn why kids aren’t just “small adults,” how to individualize transfusion decisions, and the five steps to safer blood management in your next pediatric case.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Non-Insulin Diabetes Drugs: Stop or Continue Before Surgery?

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

2 weeks ago

10 minutes 57 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic discusses the main findings from a 2025 BJA review by Tinsley et al. The study reported how to manage non-insulin diabetes medicines in the perioperative period safely. From metformin’s misunderstood safety profile to the hidden risks of SGLT-2 inhibitors and GLP-1 agonists, you’ll learn which drugs to hold, which to continue, and how to prevent complications like euglycaemic DKA and aspiration.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Regional + Local: The Pain-Relief Power Duo After Hip Surgery

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

3 weeks ago

8 minutes 35 seconds

Anesthesia Updates

A 2025 Anesthesiology meta-analysis shows that the best pain control after total hip arthroplasty comes from combining regional anesthesia with local infiltration analgesia (LIA). While LIA alone is effective, adding a quadratus lumborum or pericapsular nerve group (PENG) block significantly improves pain relief, reduces opioid use, and preserves mobility. The takeaway: stop choosing between techniques — regional + local is the new gold standard for hip surgery analgesia.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Hypotension and Delirium: No Clear Link?

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

4 weeks ago

4 minutes 5 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic unpacks a landmark 2025 study, which challenges the long-held belief that intraoperative hypotension (MAP < 65 mm Hg) contributes to postoperative delirium in older adults. With nearly 40,000 patients analyzed and no association found, it’s time to rethink reflexively chasing MAP thresholds. Tune in to hear why blood pressure might not be the villain we thought, and what really matters for preventing POD.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Block, Reverse, Remember: Cutting Delirium Risk After Anesthesia

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

1 month ago

6 minutes 30 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic delves into a 2025 study, which analyzed over 53,000 surgical cases. The key finding? Neuromuscular blockers increase the risk of postoperative delirium in older adults, unless they’re properly reversed. Whether you use sugammadex or neostigmine, reversal agents significantly reduce this risk. Tune in to hear what this means for your clinical practice and how small changes in perioperative management can make a significant impact on cognitive outcomes.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Myocardial Injury Under the Radar

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

1 month ago

7 minutes 40 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic unpacks the latest evidence on pharmacologic agents for perioperative cardioprotection in noncardiac surgery. From beta-blockers and statins to the evolving debate around RAAS inhibitors and aspirin, we cover what works, what doesn’t, and what’s still unclear. Plus, we discuss whether tighter blood pressure control or postoperative therapy intensification makes a difference. Tune in for practical, evidence-based takeaways to improve cardiac outcomes in your surgical patients.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Anemia and Transfusion in Children: Hidden Risks in Plain Sight

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

1 month ago

10 minutes 7 seconds

Anesthesia Updates

In this episode, Dr. Hadzic discusses the main findings from a new study from the British Journal of Anaesthesia (2025). The study reported that 1 in 4 children having noncardiac surgery has preoperative anemia, and that both anemia and transfusion independently, and especially together, increase 30-day mortality and complications. Despite strong global guidelines for blood management and anesthesia care in adults, pediatric blood management remains under-implemented. Learn how this data can transform your pre-op protocols, and what steps you can take right now to improve pediatric surgical outcomes.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Anesthesia for the Diabetic Parturient

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

1 month ago

8 minutes 59 seconds

Anesthesia Updates

In this episode of UPDATES IN ANESTHESIOLOGY, Dr. Hadzic reviews a 2025 paper from Anesthesiology on managing obstetric anesthesia for patients with diabetes. From prelabor planning to postpartum glucose shifts, this episode covers everything you need to provide safe and effective anesthesia care for this growing population of high-risk parturients.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

AI in Anesthesiology: Hype, Reality, and What Comes Next

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

2 months ago

7 minutes 46 seconds

Anesthesia Updates

In this episode of the NYSORA Podcast: Updates in Anesthesiology, Dr. Hadzic breaks down what anesthesiologists need to know about using AI in clinical practice. We cover recent studies showing where AI like ChatGPT performs well (like data analysis) — and where it can be risky, especially in complex patient cases. You’ll also learn how NYSORA’s Anesthesia Assistant App, powered by Maia, gives you fast, reliable answers at the bedside—built on peer-reviewed content and reviewed by experts.
What you’ll get:

When to trust AI—and when not to
How NYSORA’s app supports safe, informed decisions
Real tips you can apply in practice today

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

LinkedIn- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠

--------------------------------------------------------- ⁠⁠

Hepatopulmonary Syndrome: What Anesthesiologists Must Know

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

2 months ago

6 minutes 52 seconds

Anesthesia Updates

In this episode of UPDATES IN ANESTHESIOLOGY, Dr. Hadzic unpacks Hepatopulmonary Syndrome (HPS), a frequently missed but life-threatening complication of chronic liver disease. Drawing on a 2025 review from Current Opinion in Anesthesiology, we cover the mechanisms of HPS, key diagnostic clues like platypnea and orthodeoxia, and why liver transplantation remains the only curative therapy. You’ll also learn why MELD exception points are reshaping transplant access, the limits of emerging drug therapies, and practical anesthesia management tips for these challenging patients.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Taming Postoperative Delirium: Guideline Updates You Need to Know

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

2 months ago

9 minutes 37 seconds

Anesthesia Updates

In this episode of NYSORA’s Updates in Anesthesiology, Dr. Hadzic breaks down the 2024 ESAIC guidelines on postoperative delirium (POD) in adults. Discover the latest evidence on risk factors, why inflammation, not just anesthesia, may be the real culprit, and why multicomponent nonpharmacological strategies are your best bet. Learn what works, what doesn’t, and how to protect your patients from this common yet preventable complication. Stay ahead of the curve with this essential update for every perioperative clinician.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Pain, Pills, and Pitfalls: Analgesic Harms in Multimorbid Patients

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

2 months ago

7 minutes 27 seconds

Anesthesia Updates

In this episode, Dr. Hadzic unpacks a 2025 British Journal of Anaesthesia systematic review led by Dr. Grant and colleagues, exploring the hidden dangers of common analgesics, opioids, NSAIDs, and gabapentinoids in patients with multiple chronic conditions. With over 2.6 million patients studied, the findings reveal clear red flags and critical evidence gaps. Tune in for practical insights, risk-reduction strategies, and what this means for your everyday prescribing decisions.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Sugammadex: The Reversal Agent with a catch?

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

3 months ago

8 minutes 56 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic unpacks the latest evidence on sugammadex-induced anaphylaxis from the 2025 Anesthesiology review by Dr. Savic and colleagues. We explore the benefits that make sugammadex the preferred reversal agent over neostigmine, and the rare but serious risk of hypersensitivity reactions. You'll learn about proposed mechanisms, diagnostic pitfalls, global incidence data, and what this all means for your daily anesthesia practice. Stay informed, stay prepared, and make safer clinical choices.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Sugammadex vs Neostigmine: A Faster Recovery for Bariatric OSA Patients?

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

3 months ago

8 minutes 45 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic reviews a double-blind RCT from Anesthesia & Analgesia (March 2025) led by Dr. Ajetunmobi and colleagues. The study compared sugammadex and neostigmine for neuromuscular blockade reversal in morbidly obese patients with OSA undergoing bariatric surgery. Despite sugammadex’s pharmacologic advantages, the study found no significant difference in OR discharge times between the agents. Join us as we analyze the data, explore potential explanations, and discuss the practical implications for your anesthesia practice.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

AI vs Anesthesiology: Can Chatbots Replace Clinical Judgment?

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

3 months ago

8 minutes 4 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic discusses a 2025 study by Corpman et al. evaluating ChatGPT-4, Bard, and other AI chatbots as decision support tools in regional anesthesia. The findings? AI is getting smarter, but it still makes major clinical errors. Enter MAIA, NYSORA’s purpose-built AI assistant, designed by anesthesiologists to bridge the gap between innovation and safe practice. Tune in to hear why general AI tools may not be ready for primetime—and how MAIA sets a new standard in anesthesia decision support.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Better Blood, Better Outcomes: The Real Power of PBM in Joint Surgery

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

3 months ago

7 minutes 28 seconds

Anesthesia Updates

In this episode of UPDATES IN ANESTHESIOLOGY, Dr. Hadzic breaks down a landmark study by Garcia-Casanovas et al., published in Anesthesiology (July 2025), involving over 30,000 joint arthroplasty patients across 43 hospitals. The study shows that higher adherence to patient blood management (PBM) guidelines isn't just about fewer transfusions; it leads to fewer complications, shorter hospital stays, and better outcomes across the board. Tune in to hear why delivering PBM as a bundled strategy, not piecemeal, is key, and walk away with actionable tips to improve patient safety and performance in your own practice.\

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

New Guidelines Favor Restrictive Platelet Transfusion

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

3 months ago

7 minutes 50 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic reviews the newly published 2025 international clinical practice guidelines on platelet transfusion, co-led by Dr. Ryan Metcalf from the University of Utah and Dr. Simon Stanworth from Oxford, and published in JAMA. Based on evidence from over 30 studies, these guidelines recommend restrictive platelet transfusion thresholds in both adult and pediatric populations, advocating for transfusions only when platelet counts are critically low in specific scenarios. The goal? Minimize unnecessary transfusions, reduce patient harm, and conserve resources without increasing bleeding or mortality.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

The Silent Stroke: Unmasking Hidden Brain Injuries After Surgery

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

4 months ago

9 minutes 23 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic breaks down the results from the PRECISION study published in Anesthesiology (2025). Led by Dr. Cui and colleagues, this prospective trial reveals that nearly 1 in 9 older patients undergoing noncardiac surgery, especially neurosurgical, experience covert strokes detectable only by MRI. These “silent” strokes double the risk of postoperative delirium and long-term cognitive decline. Tune in to hear what this means for perioperative care, how to identify patients at risk, and actionable strategies to protect brain health after surgery.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

Going Green in the OR: TIVA vs Gas – Who Wins the Carbon Battle?

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

4 months ago

7 minutes 54 seconds

Anesthesia Updates

In this episode of Updates in Anesthesiology, Dr. Hadzic breaks down the largest real-world study to date comparing the environmental impact of general anesthesia strategies. With over 35,000 cases analyzed, discover why TIVA with propofol has emerged as the lowest carbon emitter, outperforming even optimized sevoflurane techniques. We’ll explore the GHG numbers, plastic waste concerns, and clinical outcomes, and conclude with practical tips to make your OR practice more sustainable without compromising patient care.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠